Health Information Technology, Quality of Care, and Evidence-based Medicine: An Interlinked Triad
Dr. Clancy describes her hopes for three health care revolutions at once: * A biomedical revolution, where radically new and successful therapies become available. * A quality revolution, to help us put effective treatments to work. * And a third revolution, where individuals are empowered with the information and the capacity they need to achieve high-quality health care and high-quality health results.

Identification of priorities for medication safety in neonatal intensive cared
Using the Failure mode and effects analysis (FMEA) framework and a systems-based approach, an eight-member multidisciplinary panel worked as a team to create a flow diagram of the neonatal unit medication use process. The panel identified 72 failures, with 193 associated causes and effects. Vulnerabilities were found to be distributed across the entire process, but multiple failures and associated causes were possible when prescribing the medication and when preparing the drug for administration. The top ranking issue was a perceived lack of awareness of medication safety issues (RPS score 273), due to a lack of medication safety training. The next highest ranking issues were found to occur at the administration stage.

AHRQ National Resource Center for Health Information Technology offers State-of-the-Art Teleconferences on Making Health IT Work
Need help figuring out the nuts and bolts of making health information technology (IT) work for your organization? Three state-of-the art teleconferences sponsored by the Agency for Healthcare Research and Quality's (AHRQ) National Resource Center for Health Information Technology will walk you through the steps of 3 challenging enterprises: external collaboration, EHR readiness assessment, and health IT implementation. All three national conferences are free and open to the public.

THE Ottawa Hospital implements first all Java electronic health record - Oacis EHR
In addition to the clinician-driven capabilities of Oacis EHR, its open architecture and proven technology platform offer a unique ability to fully interoperate with currently installed systems. This system is the first commercial IT solutions supplier to fully incorporate Sun Microsystems' Java programming language throughout an entire electronic health record system.

The Commission on Systemic Interoperability releases "Ending the Document Game: Connecting and Transforming Your Healthcare Through Information Technology"
The Commission organized the steps needed to create such a system into three categories: adoption, interoperability, and connectivity. In addition to the recommendations made by the Commissioners, this report includes many other resources including a timeline that describes steps to create an electronic prescription drug record for every American.

Interventions to regulate ordering of serum magnesium levels: report of an unintended consequence of decision support
A clinical decision support intervention intended to regulate testing increased test order rates as an unintended result of decision support. CPOE implementers must carefully design resource-related interventions and monitor their impact over time.

Researchers have built one of the world's smallest controllable robots—a machine tinier than the period that ends this sentence
The machine can take thousands of "steps" per second, though each step is a tiny 10 nanometers (a nanometer is one billionth of a meter). It is tireless and, for its size, amazingly fast. In half an hour, the robot can cover a foot (a third of a meter) in some 35 million steps. For a human, a proportionately similar stroll would lead half way around the world.

Interactive Health Communication Applications for people with chronic disease
Interactive Health Communication Applications appear to have largely positive effects on users, in that users tend to become more knowledgeable, feel better socially supported, and may have improved behavioural and clinical outcomes compared to non-users. There is a need for more high quality studies with large sample sizes to confirm these preliminary findings, to determine the best type and best way to deliver IHCAs, and to establish how IHCAs have their effects for different groups of people with chronic illness.